Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.
Saved in:
| Title: | Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma. |
|---|---|
| Authors: | Mariniello K; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Pittaway JFH; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Altieri B; Division of Endocrinology and Diabetes, Dept. of Medicine, University Hospital, University of Würzburg, Würzburg, Germany., Borges KS; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Stem Cell Institute, Cambridge, Massachusetts, USA., Hadjidemetriou I; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Ribeiro C; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Stem Cell Institute, Cambridge, Massachusetts, USA., Ruiz-Babot G; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technical, University Dresden, Dresden, Germany., Tourigny DS; School of Mathematics, University of Birmingham, Birmingham, UK., Lim JA; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Foster J; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK., Cleaver J; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK., Sosabowski J; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK., Rahman N; Institute of Biomedicine, University of Turku, Turku, Finland., Doroszko M; Institute of Biomedicine, University of Turku, Turku, Finland., Hantel C; Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland., Sigala S; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Abate A; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Tamburello M; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Kiseljak-Vassiliades K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.; Division of Endocrinology, Metabolism and Diabetes at Rocky Mountain Regional Veterans Affair Medical Center, Washington, District of Columbia, USA., Wierman M; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.; Division of Endocrinology, Metabolism and Diabetes at Rocky Mountain Regional Veterans Affair Medical Center, Washington, District of Columbia, USA., Hall C; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Parvanta L; Department of Surgery, St Bartholomew's Hospital, West Smithfield, London, UK., Abdel-Aziz TE; Department of Surgery, University College London Hospitals NHS Foundation Trust, London, UK., Chung TT; Department of Endocrinology, University College London Hospitals NHS Foundation Trust, London, UK., Marco AD; Department of Endocrine and Thyroid Surgery, Hammersmith Hospital, Imperial College London, London, UK., Palazzo F; Department of Endocrine and Thyroid Surgery, Hammersmith Hospital, Imperial College London, London, UK., Gomez-Sanchez CE; Endocrine Section, G.V. (Sonny) Montgomery VA Medical Center and the Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Taylor DR; Department of Clinical Biochemistry (Synnovis Analytics), King's College Hospital, London, UK., Rayner O; Department of Clinical Biochemistry (Synnovis Analytics), King's College Hospital, London, UK., Ronchi CL; Institute of Metabolism and System Research College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Gaston-Massuet C; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Sbiera S; Division of Endocrinology and Diabetes, Dept. of Medicine, University Hospital, University of Würzburg, Würzburg, Germany., Drake WM; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Rognoni E; Centre for Cell Biology & Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Kroiss M; Division of Endocrinology and Diabetes, Dept. of Medicine, University Hospital, University of Würzburg, Würzburg, Germany.; Department of Internal Medicine IV, LMU University Hospital, LMU Munich, München, Germany., Breault DT; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Stem Cell Institute, Cambridge, Massachusetts, USA., Fassnacht M; Division of Endocrinology and Diabetes, Dept. of Medicine, University Hospital, University of Würzburg, Würzburg, Germany., Guasti L; Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. |
| Source: | Cancer communications (London, England) [Cancer Commun (Lond)] 2025 Jun; Vol. 45 (6), pp. 663-668. Date of Electronic Publication: 2025 Mar 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2523-3548 |
|---|---|
| DOI: | 10.1002/cac2.70012 |
